Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455

Cancer statistics, 2012

Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679

Integrated genomic analyses of ovarian carcinoma

Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683

Generalized lacZ expression with the ROSA26 Cre reporter strain

Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers

Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634

Rethinking ovarian cancer: recommendations for improving outcomes

Vaughan, S., Coward, J. I. G., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. P., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3144 · Cited by 1,484

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

Alsop, K., Fereday, S., Meldrum, C. J., DeFazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M. J., Webb, P. M., Stewart, C. J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8545 · Cited by 1,204

Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C. M., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,114

Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling

Colina, J. A., Varughese, P., Karthikeyan, S., Salvi, A., Modi, D., & Burdette, J. E. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz127 · Cited by 18

Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study

Bogaerts, J. M. A., van Bommel, M. H. D., Hermens, R., Steenbeek, M. P., de Hullu, J. A., van der Laak, J. A. W. M., & Simons, M. (2023) · Histopathology · doi:10.1111/his.14902 · Cited by 17

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma

Lewis, F., Beirne, J., Henderson, B., Norris, L., Cadoo, K. A., Kelly, T. E., Martin, C. M., Hurley, S. M., Kanjuga, M., O’Driscoll, L., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217279 · Cited by 17

Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome

Gao, B., Lindemann, K. Y., Anderson, L. A., Fereday, S., Hung, J. A., Alsop, K., Tothill, R. W., Gebski, V., Kennedy, C. J., Balleine, R. L., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.06.023 · Cited by 17

Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts

Wang, J., Cheng, F. H. C., Tedrow, J., Chang, W., Zhang, C., & Mitra, A. K. (2020) · Cancers · doi:10.3390/cancers12113184 · Cited by 17

Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2

Russo, A., Colina, J. A., Moy, J., Baligod, S., Czarnecki, A. A., Varughese, P., Lantvit, D. D., Dean, M., & Burdette, J. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03663-2 · Cited by 17

Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids

Maru, Y., Tanaka, N., Tatsumi, Y., Nakamura, Y., Yao, R., Noda, T., Itami, M., & Hippo, Y. (2021) · The Journal of Pathology · doi:10.1002/path.5752 · Cited by 17

Epithelial Tumors of the Ovary

Seidman, J. D., Ronnett, B. M., Shih, I., Cho, K. R., & Kurman, R. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_14 · Cited by 19

MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location

Tirodkar, T. S., Budiu, R. A., Elishaev, E., Zhang, L., Mony, J. T., Brozick, J., Edwards, R. P., & Vlad, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102409 · Cited by 17

Death-ision: the link between cellular resilience and cancer resistance to treatments

Baldassarre, G., de la Serna, I. L., & Vallette, F. M. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02339-1 · Cited by 17

Why the dual origins of high grade serous ovarian cancer matter

Colvin, E. K., & Howell, V. M. (2020) · Nature Communications · doi:10.1038/s41467-020-15089-z · Cited by 16

PAX8, an Emerging Player in Ovarian Cancer

Gokulnath, P., Soriano, A. A., de Cristofaro, T., Palma, T. D., & Zannini, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73359-9_6 · Cited by 16

Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma

Wu, J., Raz, Y., Recouvreux, M. S., Diniz, M. A., Lester, J., Karlan, B. Y., Walts, A. E., Gertych, A., & Oršulić, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.853755 · Cited by 16

Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention

Karnezis, A. N., & Cho, K. R. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000312 · Cited by 17

Frontiers in the Pathology and Pathogenesis of Ovarian Cancer

Soong, T. R., Dinulescu, D. M., Xian, W., & Crum, C. P. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.07.013 · Cited by 16

The many microenvironments of ovarian cancer

Micek, H. M., Visetsouk, M. R., Fleszar, A. J., & Kreeger, P. K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_12 · Cited by 14

3D dynamic cultures of HGSOC organoids to model innovative and standard therapies

Cavarzerani, E., Caligiuri, I., Bartoletti, M., Canzonieri, V., & Rizzolio, F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1135374 · Cited by 15

The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer

Marjamaa, A., Gibbs, B. E., Kotrba, C., & Masamha, C. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-44548-y · Cited by 15

Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer

Russo, A., Yang, Z., Moyle-Heyrman, G., Cain, B. P., Carrero, A. L., Isenberg, B. C., Dean, M., Coppeta, J. R., & Burdette, J. E. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215779 · Cited by 15

Of mice and women - Non-ovarian origins of “ovarian” cancer

Karnezis, A. N., & Cho, K. R. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.11.039 · Cited by 15

Assessing the roles of collagen fiber morphology and matrix stiffness on ovarian cancer cell migration dynamics using multiphoton fabricated orthogonal image-based models

Alkmin, S., Patankar, M. S., & Campagnola, P. J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.037 · Cited by 13

PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification

Zhang, X., Wang, A., Han, L. M., Liang, B., Allard, G. M., Diver, E., & Howitt, B. E. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100106 · Cited by 14

Potential drug repurposing of ruxolitinib to inhibit the JAK / STAT pathway for the treatment of patients with epithelial ovarian cancer

Yunianto, I., Currie, M. J., Chitcholtan, K., & Sykes, P. H. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15761 · Cited by 14

Vaginal Bacteria Elicit Acute Inflammatory Response in Fallopian Tube Organoids

Yu, B., Nguyen, E. B., McCartney, S., Strenk, S., Valint, D., Liu, C., Haggerty, C., & Fredricks, D. N. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01350-5 · Cited by 15

Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis—Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding

Otsuka, I., & Matsuura, T. (2020) · Diagnostics · doi:10.3390/diagnostics10020120 · Cited by 14

Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis

Kobayashi, H., Ogawa, K., Kawahara, N., Iwai, K., Niiro, E., Morioka, S., & Yamada, Y. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1383605 · Cited by 14

Distinct niche structures and intrinsic programs of fallopian tube and ovarian surface epithelial cells

Qin, G. T., Park, E., Chen, X., Han, S., Xiang, D., Ren, F., Liu, G., Chen, H., Yuan, G., & Li, Z. (2022) · iScience · doi:10.1016/j.isci.2022.105861 · Cited by 13

The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer

Koç, N., Ayas, S., & Uygur, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.089 · Cited by 13

Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma

Hua, Y., Choi, P., Trachtenberg, A. J., Ng, A. C., Kuo, W. P., Ng, S., Dinulescu, D. M., Matzuk, M. M., Berkowitz, R. S., & Ng, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11808 · Cited by 13

The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers

Henderson, E. C., Huynh, G. T., Wilson, K., Plebanski, M., & Corrie, S. R. (2021) · Biomedicines · doi:10.3390/biomedicines9111554 · Cited by 14

Dissection of transcriptome dysregulation and immune characterization in women with germline BRCA1 mutation at single-cell resolution

Yu, X., Lin, W., Spirtos, A. N., Wang, Y., Chen, H., Ye, J., Parker, J. E., Liu, C. C., Wang, Y., Quinn, G. M., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02489-9 · Cited by 13

Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer

Halabi, N. M., Martínez, A., Farsi, H. F. A., Mery-Lamarche, E., Puydenus, L., Pujol, P., Khalak, H. G., McLurcan, C., Ferron, G., Querleu, D., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005755 · Cited by 13

Current Preclinical Models of Ovarian Cancer

Tisato, E. K. V. (2015) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000220 · Cited by 13

Platelet-Derived Growth Factor in the Ovarian Follicle Attracts the Stromal Cells of the Fallopian Tube Fimbriae

Yeh, C.-H., Chen, P., Chen, C.-H., Hsu, C., Huang, R., Ding, D., & Chu, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158266 · Cited by 13

Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid

Brachova, P., Alvarez, N. S., Voorhis, B. J. V., & Christenson, L. K. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.017 · Cited by 13

Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction

Gockley, A. A., & Elias, K. M. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.004 · Cited by 15

Loss of tubal ciliated cells as a risk for “ovarian” or pelvic serous carcinomaPreprint

Wang, Y., Lin, W., Wang, Y., Wang, Y., Chambers, S. K., Li, B., Lea, J. S., & Zheng, W. (2020) · doi:10.21203/rs.3.rs-39624/v1 · Cited by 13

Rethinking ovarian cancer III: the past decade and future directions

Balkwill, F. R., Laumont, C. M., Burdett, N. L., Saux, O. L., Garsed, D. W., Grither, W. R., Nijhuis, A. M., Recouvreux, M. S., Kang, Z., Zhang, R., et al. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00916-0 · Cited by 12

Advances in the role of GPX3 in ovarian cancer (Review)

Geng, D., Zhou, Y., & Wang, M. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5619 · Cited by 12

Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models

Bortolamiol, E., Mauceri, M., Piccolo, R., Cavarzerani, E., Demitri, N., Donati, C., Gandin, V., Kranjc, S., Kamenšek, U., Čemažar, M., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01203 · Cited by 12

Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers

Moser, S. C., & Jonkers, J. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1326 · Cited by 13

Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma

Mi, D., Zhang, Y.-X., Wang, C.-J., Feng, Q., Qi, P., & Chen, S. (2016) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13053 · Cited by 12

Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells

Chhabra, R., Rockfield, S., Guergues, J., Nadeau, O. W., Hill, R. G., Stevens, S. M., & Nanjundan, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-85342-y · Cited by 12

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Virani, S., Baiocchi, G., Bowtell, D. D. L., Cabasag, C. J., Cho, K. R., Fortner, R. T., Fujiwara, K., Kim, J., Köbel, M., Kurtz, J., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab043 · Cited by 12

Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives

Maru, Y., & Hippo, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.798628 · Cited by 11

From a Passive Conduit to Highly Dynamic Organ. What are the Roles of Uterine Tube Epithelium in Reproduction?

Csöbönyeiová, M., Varga, I., Lapides, L., Pavlíková, L., Feitscherova, C., & Klein, M. (2022) · Physiological Research · doi:10.33549/physiolres.934954 · Cited by 12

Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer

Yang, S., Green, A., Virani, N. A., Robinson, A., Senat, M., Testino, B., Dinulescu, D. M., & Sridhar, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1175617 · Cited by 12

In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans

Nepomuceno, A. I., Shao, H., Jing, K., Ma, Y., Petitte, J. N., Idowu, M. O., Muddiman, D. C., Fang, X., & Hawkridge, A. M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8862-4 · Cited by 12

Diseases of the Fallopian Tube and Paratubal Region

VANG, R. S. (2018) · Springer eBooks · doi:10.1007/978-1-4614-3165-7_11-2 · Cited by 12

Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria

Tiourin, E., Velasco, V. S., Rosales, M. A., Sullivan, P. S., Janzen, D. M., & Memarzadeh, S. (2015) · Reproductive Sciences · doi:10.1177/1933719115574345 · Cited by 12

Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma

Tone, A. A. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000313 · Cited by 12

BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model

He, Y., Rivera, J., Dióssy, M., Duan, H., Bowman-Colin, C., Reed, R., Jennings, R. B., Novak, J. S. S., Tran, S., Cohen, E. F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108421118 · Cited by 12

Single and Multiple Gene Manipulations in Mouse Models of Human Cancer

Lehman, H. L., & Stairs, D. B. (2015) · Cancer Growth and Metastasis · doi:10.4137/cgm.s21217 · Cited by 13

Ovulation Enhances Intraperitoneal and Ovarian Seedings of High-Grade Serous Carcinoma Cells Originating from the Fallopian Tube: Confirmation in a Bursa-Free Mouse Xenograft Model

Hsu, C., Seenan, V., Wang, L.-Y., & Chu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116211 · Cited by 11

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas

Machino, H., Dozen, A., Konaka, M., Komatsu, M., Nakamura, K., Ikawa, N., Shozu, K., Asada, K., Kaneko, S., Yoshida, H., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01090-1 · Cited by 11

Aged and BRCA -Mutated Stromal Cells Drive Epithelial Cell Transformation

Garcia, G. L., Orellana, T. J., Gorecki, G., Frisbie, L. G., Baruwal, R., Suresh, S., Goldfeld, E., Beddows, I., MacFawn, I., Britt, A. K., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0805 · Cited by 11

Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion

Lv, X., Liu, J., Ruan, J., Chen, P., He, C., Zhao, X., Huang, C., Chen, L., Wang, H., Hua, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57697-7 · Cited by 11

Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics

Mikulak, J., Terzoli, S., Marzano, P., Cazzetta, V., Martiniello, G., Piazza, R., Viano, M. E., Vitobello, D., Portuesi, R., Grizzi, F., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07557-5 · Cited by 11

Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets

Makhmut, A., Dragomir, M. P., Fritzsche, S., Möbs, M., Schmitt, W., TAUBE, E. T., & Coscia, F. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00168-4 · Cited by 12

A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs

Nagaraj, A. B., Joseph, P. L., Ponting, E., Federov, Y., Singh, S., Cole, A., Lee, W., Yoon, E., Baccarini, A., Scacheri, P. C., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.002 · Cited by 11

PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer

Fares, F., Berger, L., Girsh, E., Kakun, R. R., Ghannam-Shahbari, D., Tabach, Y., Zohar, Y., Gottlieb, E., & Perets, R. (2021) · Oncogene · doi:10.1038/s41388-021-01925-z · Cited by 11

Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas

Renner, C. M., Gomez, C., Visetsouk, M. R., Taha, I. N., Khan, A., McGregor, S. M., Weisman, P. S., Naba, A., Masters, K. S. B., & Kreeger, P. K. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211061359 · Cited by 10

Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

Serebriiskii, I. G., Pavlov, V. A., Andrianov, G. V., Litwin, S., Basickes, S., Newberg, J. Y., Frampton, G. M., Meyer, J. E., & Golemis, E. A. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00384-7 · Cited by 11

Human fallopian tube proteome shows high coverage of mesenchymal stem cells associated proteins

Wang, C., Liu, Y., Chang, C., Wu, S., Gao, J., Zhang, Y., Chen, Y., Zhong, F., & Deng, G. (2016) · Bioscience Reports · doi:10.1042/bsr20150220 · Cited by 11

ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells

Chen, C., Buj, R., Dahl, E. S., Leon, K. E., & Aird, K. M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05097 · Cited by 11

The Enigma of p53Preprint

Lozano, G. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031062 · Cited by 11

Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer

Wang, Y., Situ, X., Cárdenas, H., Siu, E., Alhunayan, S. A., Keathley, R., Tanner, E. J., Wei, J., Tan, Y., Dessai, C. V. P., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2368 · Cited by 10

PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma

Spear, S., Saux, O. L., Mirza, H., Iyer, N., Tyson, K., Freile, F. G., Walton, J. B., Woodman, C. A., Jarvis, S., Ennis, D. P., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3890 · Cited by 11

Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium

van der Ploeg, P., Uittenboogaard, A., Bosch, S. L., van Diest, P. J., Wesseling-Rozendaal, Y. J. W., van de Stolpe, A., Lambrechts, S., Bekkers, R. L. M., & Piek, J. M. J. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.01.027 · Cited by 10

Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer

Martínez, A., Delord, J., Ayyoub, M., & Devaud, C. (2020) · Cancers · doi:10.3390/cancers12071761 · Cited by 11

Cellular Origins and Lineage Plasticity in CancerPreprint

Pitarresi, J. R., & Stanger, B. Z. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041389 · Cited by 10

Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes

Govindarajan, M., Ignatchenko, V., Ailles, L., & Kislinger, T. (2022) · Biomolecules · doi:10.3390/biom13010075 · Cited by 9

Clinical and Pathological Characteristics of Incidental Diagnostic Early Occult Malignancy After Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers

Lavie, O., Moskoviz, M. G., Auslender, R., Gemer, O., Bitterman, A., Younes, G., & Segev, Y. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000624 · Cited by 9

Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer

Paris, E. A., Bahr, J. M., Bitterman, P., Basu, S., Abramowicz, J. S., & Barua, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255007 · Cited by 9

Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib

Avan, A., Adema, A. D., Hoebe, E. K., Huijts, C. M., Avan, A., Veal, G. J., Ruijtenbeek, R., Wosikowski, K., & Peters, G. J. (2014) · Current Drug Targets · doi:10.2174/1389450115666141107110321 · Cited by 9

Integrated Molecular Profiling Studies to Characterize the Cellular Origins of High-Grade Serous Ovarian CancerPreprint

Lawrenson, K., Fonseca, M. A., Segato, F., Lee, J. M., Corona, R. I., Seo, J.-H., Coetzee, S. G., Lin, Y. G., Pejovic, T. B., Mhawech-Fauceglia, P. Y., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/330597 · Cited by 9

PAX8 orchestrates an angiogenic program through interaction with SOX17Preprint

Chaves‐Moreira, D., Mitchell, M. A., Arruza, C., Rawat, P., Sidoli, S., Nameki, R. A., Reddy, J., Corona, R. I., Ma, S., Winterhoff, B. J. N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.290387 · Cited by 9

Salpingectomy for ectopic pregnancy reduces ovarian cancer risk—a nationwide study

Yen, J., Wu, T.-I., Stone, R. L., Wang, T., Visvanathan, K., Chen, L., Hsu, M., & Shih, I. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae027 · Cited by 8

Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules

Timofeeva, A. V., Asaturova, A. V., Sannikova, M. V., Khabas, G. N., Chagovets, V., Fedorov, I. S., Евгеньевич, Ф. В., & Sukhikh, G. T. (2022) · Life · doi:10.3390/life12122017 · Cited by 8

MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model

Blackman, A. M., Rees, A. C., Bowers, R. R., Jones, C. M., Vaena, S. G., Clark, M. A., Carter, S., Villamor, E. D., Evans, D. R., Emanuel, A. J., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0144 · Cited by 8

Carcinoma of the Ovaries and Fallopian Tubes

Coleman, R. L., Liu, J., Matsuo, K., Thaker, P. H., Westin, S. N., & Sood, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00086-4 · Cited by 8

Defining fallopian tube‐derived miRNA cancer signatures

Dejene, S. B., Öhman, A., Du, W., Randhawa, D., Bradley, A., Yadav, N., Elias, K. M., Dinulescu, D. M., & Setlur, S. R. (2019) · Cancer Medicine · doi:10.1002/cam4.2416 · Cited by 8

Does the “Devil” originate from the fallopian tubes?

Bairi, K. E., Jarroudi, O. A., Page, C. L., & Afqir, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.018 · Cited by 8

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy

Leng, X., Kou, S., Lin, Y., Hagemann, A. R., Hagemann, I. S., Thaker, P. H., Kuroki, L. M., McCourt, C. K., Mutch, D. G., Siegel, C. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19778-1 · Cited by 8

CK2-Mediated Phosphorylation Upregulates the Stability of USP13 and Promotes Ovarian Cancer Cell Proliferation

Kwon, J., Zhang, J., Mok, B., & Han, C. (2022) · Cancers · doi:10.3390/cancers15010200 · Cited by 8

LGALS1 regulates cell adhesion to promote the progression of ovarian cancer

Li, X., Wang, H., Jia, A.-R., Cao, Y., Yang, L., & Jia, Z. (2023) · Oncology Letters · doi:10.3892/ol.2023.13912 · Cited by 8

A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State

Liu, Y., Yen, H.-Y., Austria, T., Pettersson, J., Peti‐Peterdi, J., Maxson, R. E., Widschwendter, M., & Dubeau, L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.034 · Cited by 8

Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer

He, X., Zhang, Q., Ma, L., Li, N., Chang, X., & Zhang, Y. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.181965 · Cited by 8

Epithelial stem cell culture: modeling human disease and applications for regenerative medicine

Yamamoto, Y., & Ochiya, T. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0034-9 · Cited by 9

Precision-engineered biomimetics: the human fallopian tubePreprint

Crawford, A. J., Forjaz, A., Bhorkar, I., Roy, T., Schell, D., Queiroga, V., Ren, K., Kramer, D., Bons, J., Huang, W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.06.543923 · Cited by 8

Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer

Li, J., Chen, M., Huang, D., Li, Z., Chen, Y., Huang, J., Chen, Y. Y., Zhou, Z., & Yu, Z. (2024) · MedComm · doi:10.1002/mco2.70033 · Cited by 7

Ovarian Carcinomas

Prat, J., D′Angelo, E., & Espinosa, Í. (2025) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002352 · Cited by 7

Aggressive Serous Carcinomas of the Female Reproductive Tract: Cancer-Prone Cell States and Genetic Drivers

Phuong, D. J., Pirtz, M. G., Ralston, C. Q., Cosgrove, B. D., Schimenti, J. C., Flesken‐Nikitin, A., & Nikitin, A. Y. (2025) · Cancers · doi:10.3390/cancers17040604 · Cited by 7

High PRMT5 levels, maintained by KEAP1 inhibition, drive chemoresistance in high-grade serous ovarian cancer

Öztürk, H., Seker-Polat, F., Abbaszadeh, N., Kingham, Y., Oršulić, S., & Adli, M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184283 · Cited by 8

Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53

Smith, L. E., Padilla, J. L., Licor, A., Steinkamp, M. P., Lagutina, I. V., Guo, Y. P., Devor, E. J., Pankratz, V. S., Sallmyr, A., Oyebamiji, O., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102522 · Cited by 7

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer

He, Y., Khan, T., Kryza, T., Jones, M. L., Goh, J. B., Lyons, N., Pearce, L. A., Lee, M., Gough, M., Rogers, R., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00401 · Cited by 7

Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers

Zhu, Q., Wang, J., Yu, H., Hu, Q., Bateman, N. W., Long, M. D., Rosario, S. R., SCHULTZ, E. A., Dalgard, C. L., Wilkerson, M. D., et al. (2022) · Cancers · doi:10.3390/cancers14102350 · Cited by 7

Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence

Sherman, M. E., Drapkin, R., Horowitz, N. S., Crum, C. P., Friedman, S. J., Kwon, J. S., Levine, D. A., Shih, I., Shoupe, D., Swisher, E. M., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0384 · Cited by 7

Niraparib treatment for patients with BRCA -mutated ovarian cancer: review of clinical data and therapeutic context

González-Martı́n, A., Matulonis, U. A., Korach, J., Mirza, M. R., Moore, K. N., Wu, X., York, W., Gupta, D., Lechpammer, S., & Monk, B. J. (2022) · Future Oncology · doi:10.2217/fon-2022-0206 · Cited by 7

The National Cancer Institute’s PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets

Shoemaker, R. H., Suen, C. S., Holmes, C. A., Fay, J. R., & Steele, V. E. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.008 · Cited by 7

Abstract PR01: Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in BRCA/P53 models

Wyant, G. A., Perets, R., Muto, K. W., Poole, B. B., Chen, J. Y., Öhman, A., Setlur, S. R., Crum, C. P., Drapkin, R., & Dinulescu, D. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ovca13-pr01

Mouse Models Identify a Potential Ovarian Cancer Cell of Origin

(2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2014-004

Precursors of High-Grade Serous Carcinoma

Shaw, P. A., Clarke, B. A., & George, S. H. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-22509-8_1 · Cited by 1

Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis

Soong, T. R., Kolin, D. L., Teschan, N., & Crum, C. P. (2018) · Cancers · doi:10.3390/cancers10120468 · Cited by 46

Tumorigenesis and peritoneal colonization from fallopian tube epithelium

Eddie, S. L., Quartuccio, S. M., hAinmhire, E. Ó., Moyle-Heyrman, G., Lantvit, D., Wei, J., Vanderhyden, B. C., & Burdette, J. E. (2015) · Oncotarget · doi:10.18632/oncotarget.3985 · Cited by 39